Skip to content
healthcare.dev

cytarabine

NDC 25021-229, cytarabine, injection, solution, from Sagent Pharmaceuticals.

Product NDC
25021-229
Status
Listed
Labeler
Sagent Pharmaceuticals
Dosage form
INJECTION, SOLUTION
Route
INTRATHECAL, INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211937
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25021-229 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CYTARABINE20 mg/mL

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
25021-229-05250210229055 VIAL in 1 CARTON (25021-229-05) / 5 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/90f5c7ab-9f15-487d-ba69-ee4107434bcc
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=25021-229

Use it

Look up 25021-229 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25021-229 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25021-229. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.